Allison Pagan
Family Medicine · Missouri Valley, IANPI 1295230068
Payments from drug & device makers
Across 98 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$327
- Bayer$202
- AbbVie$157
- Novo Nordisk$149
- AstraZeneca$107
- Supernus Pharmaceuticals, Inc.$90
- plus $617 from 19 others
What the payments were for
- Food & beverage$1,649100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 20 | $327 |
| Bayer | 12 | $202 |
| AbbVie | 7 | $157 |
| Novo Nordisk | 9 | $149 |
| AstraZeneca | 6 | $107 |
| Supernus Pharmaceuticals, Inc. | 6 | $90 |
| Vertex | 4 | $80 |
| Astellas Pharma US Inc | 4 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $52 |
| Pfizer | 3 | $44 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Amgen | 3 | $40 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Viatris Specialty LLC | 2 | $33 |
| Mylan Specialty L.p. | 2 | $27 |
| Boehringer Ingelheim | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Merck | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| Organon | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| GSK | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
How this compares
$1,649 in reported general payments places this provider in the 85th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 34 | $38,460 |
| MounjaroTirzepatide | 34 | $34,907 |
| JardianceEmpagliflozin | 38 | $31,906 |
| EliquisApixaban | 45 | $27,052 |
| XareltoRivaroxaban | 36 | $22,824 |
| FarxigaDapagliflozin Propanediol | 17 | $20,515 |
| Nurtec OdtRimegepant Sulfate | 17 | $18,823 |
| RybelsusSemaglutide | 12 | $18,356 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $13,493 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,175 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $8,256 |
| MyrbetriqMirabegron | 18 | $7,306 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $3,841 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $3,783 |
| GemtesaVibegron | 22 | $3,427 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $149 | $56,81646 claims |
| PfizerEliquis, Nurtec Odt | $44 | $45,87462 claims |
| Lilly USA, LLCMounjaro | $327 | $34,90734 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $107 | $34,47350 claims |
| Boehringer IngelheimJardiance | $25 | $31,90638 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $12 | $21,74937 claims |
| Astellas Pharma US IncMyrbetriq | $56 | $7,30618 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $22 | $3,42722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Missouri Valley
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.